Health
Identifying Platinum Chemotherapy Resistance in Patients With Ovarian Cancer – Technology Networks
Researchers have discovered a way to predict which patients with ovarian cancer are resistant to platinum chemotherapy.
Epithelial ovarian cancer (EOC) is the most common lethal gynaecological cancer. Ovarian cancer is usually treated with platinum-based chemotherapy; however, a significant number of patients are resistant to such treatments and relapse soon afterwards. To improve their survival, there is a need to first identify which patients may be platinum-resistant, so that newer treatments may be administered early.
Now, researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National…
-
General22 hours agoDeath of 86-year-old driver in Karoonda Highway crash prompts push for change
-
General19 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Business18 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
Noosa News22 hours agoStory Bridge documents released amid cover-up claims